Literature DB >> 3529467

Peripheral corneal disorders.

J B Robin, D J Schanzlin, S M Verity, B A Barron, R C Arffa, E Suarez, H E Kaufman.   

Abstract

The peripheral cornea is anatomically and physiologically distinct from its central counterpart. The major differences relate to the gradual transition of corneal tissues to those of the conjunctiva, episclera, and sclera; furthermore, the vascular structures, lymphatics, and inflammatory cells from these neighboring structures are intimately associated with the limbus and periphery of the cornea. The peripheral cornea is thereby predisposed to three main classes of disorders which do not normally involve the central cornea. First, local conditions affecting the sclera and conjunctiva may secondarily spread to involve the limbus and peripheral cornea. These include several infectious diseases, as well as hypersensitivity conditions, mass lesions, and degenerations. Second, due to the associated blood vessels and lymphatics, the peripheral cornea may be involved in a variety of systemic diseases, including vasculitides, autoimmune disorders, and abnormal metabolic conditions. Finally, there are several conditions, such as the noninflammatory peripheral degenerations, which primarily affect the peripheral cornea without associated ocular or systemic changes. In this review, we present a classification and discussion of the various disorders which may involve the peripheral cornea.

Entities:  

Mesh:

Year:  1986        PMID: 3529467     DOI: 10.1016/0039-6257(86)90049-4

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  12 in total

1.  Bilateral Mooren's ulcer in six patients: diagnosis, surgery and histopathology.

Authors:  Christos D Kalogeropoulos; Vassiliki D Malamou-Mitsi; Miltiadis B Aspiotis; Konstantinos G Psilas
Journal:  Int Ophthalmol       Date:  2004-01       Impact factor: 2.031

2.  National survey of pellucid marginal corneal degeneration in Japan.

Authors:  Jun Shimazaki; Naoyuki Maeda; Osamu Hieda; Yuichi Ohashi; Akira Murakami; Kohji Nishida; Kazuo Tsubota
Journal:  Jpn J Ophthalmol       Date:  2016-07-11       Impact factor: 2.447

3.  Immunosuppressives in Peripheral Ulcerative Keratitis.

Authors:  K Shyamsundar; J Biswas; K Narayanan
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 4.  Bilateral, anterior stromal ring opacity of the cornea.

Authors:  G R Melles; J P de Séra; C A Eggink; J R Cruysberg; P S Binder
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

5.  The involvement of multipotential progenitor cells in Mooren's ulcer.

Authors:  In Gul Lee; Juan Ye; Jae Chan Kim
Journal:  Yonsei Med J       Date:  2005-06-30       Impact factor: 2.759

6.  Corneal Collagen Cross-Linking in Pellucid Marginal Degeneration: 2 Patients, 4 Eyes.

Authors:  Serife Bayraktar; Zafer Cebeci; Merih Oray; Nilufer Alparslan
Journal:  Case Rep Ophthalmol Med       Date:  2015-05-11

7.  Full-Ring Intracorneal Implantation in Corneas With Pellucid Marginal Degeneration.

Authors:  Sahar Mojaled Nobari; Consuelo Villena; Khosrow Jadidi
Journal:  Iran Red Crescent Med J       Date:  2015-12-26       Impact factor: 0.611

8.  Using Anterior Segment Optical Coherence Tomography to Monitor Disease Progression in Peripheral Ulcerative Keratitis.

Authors:  Aakriti Garg; Joaquin De Rojas; Priya Mathews; Albert Hazan; James Lin; Danielle Trief; Leejee H Suh
Journal:  Case Rep Ophthalmol Med       Date:  2018-06-28

Review 9.  A Review of Corneal Endotheliitis and Endotheliopathy: Differential Diagnosis, Evaluation, and Treatment.

Authors:  Majid Moshirfar; Michael S Murri; Tirth J Shah; David F Skanchy; James Q Tuckfield; Yasmyne C Ronquillo; Orry C Birdsong; Daniel Hofstedt; Phillip C Hoopes
Journal:  Ophthalmol Ther       Date:  2019-03-11

10.  Clinical profile and demographic distribution of pellucid marginal corneal degeneration in India: A study of 559 patients.

Authors:  Anthony V Das; Lalitha N Pillutla; Sunita Chaurasia
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.